New Delhi: The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech’s application for clinical trials of its intranasal Covid vaccine as a booster or a third dose. The Hyderabad-based manufacturer has proposed the booster dose for those who have been […]
Hyderabad: Hyderabad-based Hetero, a vertically integrated pharmaceutical organisation, has received Drug Controller General of India (DCGI) nod for manufacture and marketing of molnupiravir capsules 200 mg (Movfor). Molnupiravir is an oral antiviral indicated for restricted emergency use in India to treat adult patients with Covid-19. Hetero’s Movfor will be made available in a 40 capsule […]